2007Unpublished venueRequires access

Regulatory Considerations of Drug Metabolism and Drug Interaction Studies

Xiaoxiong Wei, Mingshe Zhu

Open publisher page 2 citations

Abstract

This chapter contains sections titled: Introduction Regulatory Guidances Relevant to Drug Metabolism Metabolism Studies Relevant to Metabolite Safety Assessment Drug–Drug Interaction Studies Conclusions Acknowledgment References

About this research paper

What this paper is about

This chapter contains sections titled: Introduction Regulatory Guidances Relevant to Drug Metabolism Metabolism Studies Relevant to Metabolite Safety Assessment Drug–Drug Interaction Studies Conclusions Acknowledgment References

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

This chapter contains sections titled: Introduction Regulatory Guidances Relevant to Drug Metabolism Metabolism Studies Relevant to Metabolite Safety Assessment Drug–Drug Interaction Studies Conclusions Acknowledgment References

Key concepts: Drug, Drug metabolism, Drug-drug interaction, Pharmacology, Chemistry, Computational biology, Medicine, Biology

Related papers

Back to paper searchBrowse research topicsOriginal source
Regulatory Considerations of Drug Metabolism and Drug Interaction Studies — Research Paper | ScholarLens